Why Modern Enterprises Choose Drupal
More Than a CMS. A Composable Digital Experience Platform.
When your digital needs outgrow basic templates and rigid systems, you need a platform engineered for flexibility, scalability, and integration. Drupal is the open-source powerhouse chosen by global enterprises to build digital experiences that are secure, adaptable, and built to last.
Recent releases
Company Intranet Providers: The 2026 Buyer's Guide
The global intranet software market was valued at $18.30 billion in 2024 and is projected to reach $43.09 billion by 2032. Behind that growth sits an uncomfortable truth. Only 13 percent of employees…
Best Intranet Providers: The 2026 Buyer's Guide
Enterprise organizations routinely waste up to 40 percent of their SaaS budgets on unused software licenses.Traditional internal portals consistently rank among the lowest in daily active user…
Intranet Software Vendors: The 2026 Buyer's Guide
Standard intranet platforms cost between $5 and $50 per user per month. Applied across a global enterprise with tens of thousands of employees that per seat licensing is a substantial recurring…
Intranet Vendors: The 2026 Complete Guide
Standard intranet platforms cost between $5 and $50 per user per month. Applied across a global enterprise with tens of thousands of employees, that per-seat licensing represents a substantial and…
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
